Learning Objectives:

1: Identify clinical presentation of immune-related adverse events.

2: Appreciate novel aspects of evaluating autoimmune manifestations and use of immunosuppression agents in context of irAEs and understand its research is still quite young.

3: Be able to assess optimal immunosuppression for future irAE case presentations, optimizing IS benefits and minimizing risks.